Riskpilot← Back to searchSign inGet full accessAGRO ØRE-NESE-HALSKLINIKK AS
ASActiveOrg 897104962Bankveien 1, 1383 AskerMedical specialists activities · NACE 8622Est. 20115 employees
Revenue 2024
NOK 6,7M
+27% vs 2023
EBITDA margin
2.0%
+119% vs 2023
Equity ratio
57.7%
Financial strength
Net profit 2024
NOK 63K
+110% vs 2023
| Revenue | NOK 6,7M | +27% |
| EBITDA | NOK 136K | +119% |
| Net profit | NOK 63K | +110% |
| Total assets | NOK 1,3M | -24% |
| Equity | NOK 743K | +9% |
| Employees | 5 | — |
Legal name
AGRO ØRE-NESE-HALSKLINIKK AS
Org number
897104962
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
4. juli 2011
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Robby roarsen
Company purpose
Legevirksomhet.
Address
Bankveien 1, 1383 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 974 | 4 832 | 4 709 | 5 306 | 6 741 |
| Staff expenses | −2 429 | −2 403 | −2 379 | −2 541 | −3 024 |
| EBITDA | 45 | −136 | −414 | −728 | 136 |
| Depreciation & amort. | −118 | −123 | −66 | −86 | −55 |
| EBIT | −73 | −259 | −480 | −814 | 81 |
| Net financials | −3 | −1 | −3 | 1 | −1 |
| Profit before tax | −76 | −260 | −483 | −813 | 81 |
| Tax | −11 | −49 | −106 | −177 | 18 |
| Net profit | −64 | −210 | −377 | −635 | 63 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 292 | 867 | 1 608 | 1 689 | 1 286 |
| Equity | 624 | 413 | 680 | 680 | 743 |
| Long-term debt | 0 | 0 | 2 | 0 | 0 |
| Short-term debt | 668 | 453 | 927 | 1 009 | 544 |
| Total debt | 668 | 453 | 928 | 1 009 | 544 |
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
20202024
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
8.5%
This company
18.4%
Market median
-54% vs market
20202024
Net profit margin
0.9%
This company
8.1%
Market median
-89% vs market
20202024
Asset turnover
5.24×
This company
1.12×
Market median
+368% vs market
20202024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
AS Deputy Member | Deputy Member | 2017 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (1) | ||
| Chairman | 2017 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Dr. Roarsen As
AGRO ØRE-NESE-HALSKLINIKK AS Board members of AGRO ØRE-NESE-HALSKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Robby Roarsen | Chief Executive Officer | 0 companies |
| Anne Sophie Fylling | Deputy Member | 0 companies |
| Jenny Alvirovic | Board of Directors | 0 companies |
| Sverre Dølvik | Chairman | 0 companies |